000590 启迪药业
已收盘 07-26 15:00:00
资讯
新帖
简况
启迪药业:预计2024年1-6月归属净利润亏损2100万元至2700万元
证券之星 · 07-10
启迪药业:预计2024年1-6月归属净利润亏损2100万元至2700万元
启迪药业(000590.SZ)发预亏,预计上半年净亏损2100万元-2700万元
智通财经 · 07-10
启迪药业(000590.SZ)发预亏,预计上半年净亏损2100万元-2700万元
启迪药业(000590)7月8日主力资金净卖出198.52万元
证券之星 · 07-08
启迪药业(000590)7月8日主力资金净卖出198.52万元
启迪药业最新公告:公司副总裁、董事会秘书曹定兴因身体原因辞职
证券之星 · 07-01
启迪药业最新公告:公司副总裁、董事会秘书曹定兴因身体原因辞职
6月24日启迪药业跌5.48%,北信瑞丰中国智造基金重仓该股
证券之星 · 06-24
6月24日启迪药业跌5.48%,北信瑞丰中国智造基金重仓该股
启迪药业新提交1件商标注册申请
证券之星 · 06-14
启迪药业新提交1件商标注册申请
6月7日启迪药业涨5.17%,北信瑞丰中国智造基金重仓该股
证券之星 · 06-07
6月7日启迪药业涨5.17%,北信瑞丰中国智造基金重仓该股
启迪药业:未来如有收并购等相关重大事项,公司将严格依照法律法规要求,及时履行信息披露义务
证券之星 · 05-30
启迪药业:未来如有收并购等相关重大事项,公司将严格依照法律法规要求,及时履行信息披露义务
启迪药业(000590)5月29日主力资金净买入37.39万元
证券之星 · 05-29
启迪药业(000590)5月29日主力资金净买入37.39万元
5月28日启迪药业跌6.53%,北信瑞丰中国智造基金重仓该股
证券之星 · 05-28
5月28日启迪药业跌6.53%,北信瑞丰中国智造基金重仓该股
5月27日启迪药业涨停分析:保健品,中药,医药概念热股
证券之星 · 05-27
5月27日启迪药业涨停分析:保健品,中药,医药概念热股
加大“大健康”产业布局,启迪药业涨停
证券之星 · 05-27
加大“大健康”产业布局,启迪药业涨停
异动快报:启迪药业(000590)5月27日9点38分触及涨停板
证券之星 · 05-27
异动快报:启迪药业(000590)5月27日9点38分触及涨停板
启迪药业最新公告:衡阳市国资委拟无偿划转公司5.84%股份
证券之星 · 05-07
启迪药业最新公告:衡阳市国资委拟无偿划转公司5.84%股份
启迪药业:公司股东国有股权无偿划转
港股那点事 · 05-07
启迪药业:公司股东国有股权无偿划转
启迪药业(000590)4月26日主力资金净买入525.57万元
证券之星 · 04-26
启迪药业(000590)4月26日主力资金净买入525.57万元
启迪药业最新公告:一季度净利润亏损828.43万元 同比转亏
证券之星 · 04-25
启迪药业最新公告:一季度净利润亏损828.43万元 同比转亏
启迪药业(000590.SZ)发布一季度业绩,净亏损828.43万元
智通财经网 · 04-25
启迪药业(000590.SZ)发布一季度业绩,净亏损828.43万元
启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%
智通财经网 · 03-27
启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%
启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对
市场资讯 · 01-15
启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对
公司概况
公司名称:
启迪药业集团股份公司
所属行业:
医药制造业
上市日期:
1996-01-19
主营业务:
启迪药业集团股份公司主营业务是研究、开发中国中药传统秘方、验方和西药制剂。公司始终致力于医药大健康领域的拓展深耕,产品涵盖中药、化药、保健食品三大板块,主要产品包括中成药、西药制剂以及药食同源保健食品。作为传统中、西药生产与销售的企业,品牌与品种优势突出,是湖南省主要的医药企业之一。公司具有现代化的生产设备,产品“古汉养生精”因其独特配方,曾被评为国家秘密技术项目品种和国家中药保护品种,产品质量被市场及客户高度认可,树立了较好的市场口碑。
发行价格:
6.00
{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"启迪药业","latestPrice":5,"timestamp":1721977437000,"preClose":4.94,"halted":0,"volume":1597700,"delay":0,"floatShares":239000000,"shares":239000000,"eps":0.0434,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"07-26 15:00:00","open":4.96,"high":5.02,"low":4.95,"amount":7966100,"amplitude":0.0142,"askPrice":5,"askSize":157,"bidPrice":4.99,"bidSize":258,"shortable":0,"etf":0,"ttmEps":0.0434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":4.94,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":5.43,"lowLimit":4.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"pbRate":1.65,"roa":"--","roe":"--","epsLYR":0.1054,"committee":0.213984,"marketValue":1197000000,"floatMarketCap":1197000000,"peRate":115.207371,"changeRate":0.0121,"turnoverRate":0.0067,"status":0},"requestUrl":"/m/hq/s/000590/wiki","defaultTab":"wiki","newsList":[{"id":"2450864431","title":"启迪药业:预计2024年1-6月归属净利润亏损2100万元至2700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450864431","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450864431?lang=zh_cn&edition=full","pubTime":"2024-07-10 18:02","pubTimestamp":1720605769,"startTime":"0","endTime":"0","summary":"证券之星消息,启迪药业发布业绩预告,预计2024年1-6月归属净利润亏损2100万元至2700万元。启迪药业2024年一季报显示,公司主营收入7709.36万元,同比下降23.82%;归母净利润-828.43万元,同比下降225.81%;扣非净利润-936.01万元,同比下降287.85%;负债率38.09%,投资收益9.0万元,财务费用54.99万元,毛利率50.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000038284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"gpt_icon":0},{"id":"2450956863","title":"启迪药业(000590.SZ)发预亏,预计上半年净亏损2100万元-2700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450956863","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450956863?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:58","pubTimestamp":1720601891,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启迪药业(000590.SZ)发布2024年半年度业绩预告,公司预计上半年归属于上市公司股东的净亏损2100万元-2700万元,由盈转亏;扣除非经常性损益后的净亏损2200万元-2800万元,由盈转亏。报告期内,受医保和医药政策变化及市场环境等因素影响,公司营业总收入较去年同期出现下滑,加之部分原辅材料价格上涨等原因,导致整体毛利率及盈利水平下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2449740863","title":"启迪药业(000590)7月8日主力资金净卖出198.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449740863","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449740863?lang=zh_cn&edition=full","pubTime":"2024-07-08 15:29","pubTimestamp":1720423768,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月8日收盘,启迪药业报收于5.07元,下跌4.88%,换手率1.44%,成交量3.44万手,成交额1763.58万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:启迪药业2024年一季报显示,公司主营收入7709.36万元,同比下降23.82%;归母净利润-828.43万元,同比下降225.81%;扣非净利润-936.01万元,同比下降287.85%;负债率38.09%,投资收益9.0万元,财务费用54.99万元,毛利率50.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800014447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2448964087","title":"启迪药业最新公告:公司副总裁、董事会秘书曹定兴因身体原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2448964087","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448964087?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:41","pubTimestamp":1719826868,"startTime":"0","endTime":"0","summary":"启迪药业公告,公司董事会于2024年7月1日收到公司副总裁、董事会秘书曹定兴的辞职报告,曹定兴因身体原因申请辞去公司副总裁、董事会秘书职务,同时辞去子公司所有职务。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100022960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2445047319","title":"6月24日启迪药业跌5.48%,北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047319","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047319?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:26","pubTimestamp":1719217569,"startTime":"0","endTime":"0","summary":"证券之星消息,6月24日启迪药业跌5.48%创60日新低,收盘报5.17元,换手率1.65%,成交量3.94万手,成交额2063.36万元。重仓启迪药业的公募基金请见下表:根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元,最新净值1.178,较上一交易日上涨0.0%,近一年下跌25.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400020813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2443184646","title":"启迪药业新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2443184646","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443184646?lang=zh_cn&edition=full","pubTime":"2024-06-14 13:49","pubTimestamp":1718344163,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日启迪药业集团股份公司新提交1件商标注册申请。商标申请详情如下:今年以来启迪药业集团股份公司新申请注册商标8件,截止目前公司共持有注册商标107件,另有32件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400022153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"gpt_icon":0},{"id":"2441318610","title":"6月7日启迪药业涨5.17%,北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441318610","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441318610?lang=zh_cn&edition=full","pubTime":"2024-06-07 16:24","pubTimestamp":1717748669,"startTime":"0","endTime":"0","summary":"证券之星消息,6月7日启迪药业涨5.17%,收盘报5.7元,换手率2.55%,成交量6.11万手,成交额3463.07万元。重仓启迪药业的公募基金请见下表:根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元,最新净值1.203,较上一交易日上涨0.25%,近一年下跌20.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060700030003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2439612080","title":"启迪药业:未来如有收并购等相关重大事项,公司将严格依照法律法规要求,及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2439612080","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439612080?lang=zh_cn&edition=full","pubTime":"2024-05-30 19:02","pubTimestamp":1717066957,"startTime":"0","endTime":"0","summary":"证券之星消息,启迪药业05月30日在投资者关系平台上答复投资者关心的问题。“古汉”品牌得到市场及客户的高度认可,树立了良好的市场口碑,已被评为“中华老字号”。未来公司如有收并购等相关重大事项,将严格按照监管规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053000033707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2439518493","title":"启迪药业(000590)5月29日主力资金净买入37.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439518493","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439518493?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:23","pubTimestamp":1716967396,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月29日收盘,启迪药业报收于6.33元,下跌7.86%,换手率10.19%,成交量24.38万手,成交额1.56亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:启迪药业2024年一季报显示,公司主营收入7709.36万元,同比下降23.82%;归母净利润-828.43万元,同比下降225.81%;扣非净利润-936.01万元,同比下降287.85%;负债率38.09%,投资收益9.0万元,财务费用54.99万元,毛利率50.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052900025183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2438344355","title":"5月28日启迪药业跌6.53%,北信瑞丰中国智造基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2438344355","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438344355?lang=zh_cn&edition=full","pubTime":"2024-05-28 16:24","pubTimestamp":1716884684,"startTime":"0","endTime":"0","summary":"证券之星消息,5月28日启迪药业跌6.53%,收盘报6.87元,换手率14.5%,成交量34.71万手,成交额2.46亿元。重仓启迪药业的公募基金请见下表:根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为北信瑞丰中国智造。北信瑞丰中国智造目前规模为0.19亿元,最新净值1.251,较上一交易日上涨0.16%,近一年下跌16.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800028930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2438874701","title":"5月27日启迪药业涨停分析:保健品,中药,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2438874701","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438874701?lang=zh_cn&edition=full","pubTime":"2024-05-27 15:32","pubTimestamp":1716795178,"startTime":"0","endTime":"0","summary":"证券之星消息,启迪药业涨停收盘,收盘价7.35元。该股于9点34分涨停,2次打开涨停,截止收盘封单资金为6335.7万元,占其流通市值3.6%。5月27日的资金流向数据方面,主力资金净流入2645.12万元,占总成交额20.03%,游资资金净流出922.2万元,占总成交额6.98%,散户资金净流出1722.92万元,占总成交额13.05%。近5日资金流向一览见下表:该股为保健品,中药,医药概念热股,当日保健品概念上涨1.23%,中药概念上涨0.89%,医药概念上涨0.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700012384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK1161","000590","159938","BK0239","BK1574","BK0122","09939"],"gpt_icon":0},{"id":"2438876739","title":"加大“大健康”产业布局,启迪药业涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2438876739","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438876739?lang=zh_cn&edition=full","pubTime":"2024-05-27 14:43","pubTimestamp":1716792230,"startTime":"0","endTime":"0","summary":"营业收入中,中药及保健品占比95.06%,其他占比4.94%。该公司在年报中称,2024年,为完成公司确定的战略目标,公司将进一步加大在“大健康”产业的布局,延伸在“大健康”领域产业链,加不断强内部管理,通过强化生产过程管控,推进精细化管理,加快公司智能制造、绿色制造转型升级,降低产品成本,加强品牌宣传推广力度与营销体系及营销队伍建设,向销售网络、品牌知名度和美誉度全国化迈进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2024052700010884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2438874841","title":"异动快报:启迪药业(000590)5月27日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2438874841","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438874841?lang=zh_cn&edition=full","pubTime":"2024-05-27 09:40","pubTimestamp":1716774058,"startTime":"0","endTime":"0","summary":"证券之星5月27日盘中消息,9点38分启迪药业触及涨停板。目前价格7.35,上涨10.03%。其所属行业中药目前上涨。该股为高校系,保健品,雄安新区概念热股,当日高校系概念上涨0.33%,保健品概念上涨0.18%,雄安新区概念上涨0.12%。5月24日的资金流向数据方面,主力资金净流入32.31万元,占总成交额1.65%,游资资金净流入102.29万元,占总成交额5.23%,散户资金净流出134.6万元,占总成交额6.88%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700002719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2433327894","title":"启迪药业最新公告:衡阳市国资委拟无偿划转公司5.84%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2433327894","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433327894?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:11","pubTimestamp":1715076672,"startTime":"0","endTime":"0","summary":"启迪药业公告,衡阳市国资委决定将其持有的本公司5.84%股份无偿划转给衡阳弘湘国有投资(控股)集团有限公司。本次国有股权无偿划转实施完成后,弘湘集团将持有本公司19.11%的股份。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050700031202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2433275969","title":"启迪药业:公司股东国有股权无偿划转","url":"https://stock-news.laohu8.com/highlight/detail?id=2433275969","media":"港股那点事","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433275969?lang=zh_cn&edition=full","pubTime":"2024-05-07 17:59","pubTimestamp":1715075940,"startTime":"0","endTime":"0","summary":"格隆汇5月7日|启迪药业公告,衡阳市国资委决定将其持有的本公司13,988,705股的无限售条件股份(占公司总股本的5.84%)无偿划转给衡阳弘湘国有投资(控股)集团有限公司。本次国有股权无偿划转实施完成后,弘湘集团将持有本公司19.11%的股份。 \n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-07/doc-inaukzec1644861.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-07/doc-inaukzec1644861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2430435512","title":"启迪药业(000590)4月26日主力资金净买入525.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430435512","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430435512?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:23","pubTimestamp":1714116196,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月26日收盘,启迪药业报收于6.26元,下跌4.57%,换手率4.78%,成交量11.45万手,成交额7094.99万元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:启迪药业2024年一季报显示,公司主营收入7709.36万元,同比下降23.82%;归母净利润-828.43万元,同比下降225.81%;扣非净利润-936.01万元,同比下降287.85%;负债率38.09%,投资收益9.0万元,财务费用54.99万元,毛利率50.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600028612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2430405475","title":"启迪药业最新公告:一季度净利润亏损828.43万元 同比转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2430405475","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430405475?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:10","pubTimestamp":1714043433,"startTime":"0","endTime":"0","summary":"启迪药业披露一季度报告,公司2024年第一季度实现营业收入7709.36万元,同比下降23.82%;净利润亏损828.43万元,同比转亏。报告期内,主要受主营业务收入减少和管理费用增加的影响,净利润同比减少。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500039904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"gpt_icon":0},{"id":"2430178479","title":"启迪药业(000590.SZ)发布一季度业绩,净亏损828.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430178479","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430178479?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:39","pubTimestamp":1714037947,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启迪药业(000590.SZ)发布2024年一季度报告,报告期内实现营业收入7709.36万元,同比下降23.82%。归属于上市公司股东净亏损828.43万元。归属于上市公司股东的扣除非经常性损益净亏损936.01万元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2422998556","title":"启迪药业(000590.SZ)发布2023年度业绩,净利润2524.68万元,增长39.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422998556","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422998556?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:49","pubTimestamp":1711540140,"startTime":"0","endTime":"0","summary":"启迪药业发布2023年年度报告,该公司营业收入为4.05亿元,同比增长15.44%。归属于上市公司股东的净利润为2524.68万元,同比增长39.41%。归属于上市公司股东的扣除非经常性损益的净亏损为465.05万元。基本每股收益为0.1054元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-27/doc-inapumws3212797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000590"],"gpt_icon":0},{"id":"2403808390","title":"启迪药业拟溢价4倍收购名实药业55%股权 标的被指缺主打产品“二把手”带头反对","url":"https://stock-news.laohu8.com/highlight/detail?id=2403808390","media":"市场资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2403808390?lang=zh_cn&edition=full","pubTime":"2024-01-15 07:47","pubTimestamp":1705276020,"startTime":"0","endTime":"0","summary":" 手头并不宽裕的情况下,启迪药业依然坚持高溢价收购。 1月12日,启迪药业公告显示,公司拟以现金人民币1.41亿元的对价,收购名实药业55%股权。其中,倪小桥还是副董事长、党委书记,为公司“二把手”。 倪小桥、唐婷认为,名实药业缺主打产品,未来市场核心竞争力弱。 当前,启迪药业业绩并不理想,公司2023年前三季度净利润仅643.01万元,同比下滑59.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-01-15/doc-inacqcyi8266609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000590","BK0239","BK0122"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0573},{"period":"3month","weight":-0.2109},{"period":"6month","weight":-0.4354},{"period":"1year","weight":-0.4374},{"period":"ytd","weight":-0.4487}],"companyName":"启迪药业集团股份公司","boardCode":"AI0027","perCapita":"11326股","boardName":"医药制造业","registeredCapital":"23947万元","compareEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0654},{"period":"6month","weight":-0.0081},{"period":"1year","weight":-0.1043},{"period":"ytd","weight":-0.0296}],"survey":" 启迪药业集团股份公司主营业务是研究、开发中国中药传统秘方、验方和西药制剂。公司始终致力于医药大健康领域的拓展深耕,产品涵盖中药、化药、保健食品三大板块,主要产品包括中成药、西药制剂以及药食同源保健食品。作为传统中、西药生产与销售的企业,品牌与品种优势突出,是湖南省主要的医药企业之一。公司具有现代化的生产设备,产品“古汉养生精”因其独特配方,曾被评为国家秘密技术项目品种和国家中药保护品种,产品质量被市场及客户高度认可,树立了较好的市场口碑。","serverTime":1722000619098,"listedPrice":6,"stockholders":"21135人(较上一季度减少1.28%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"启迪药业,000590,启迪药业股票,启迪药业股票老虎,启迪药业股票老虎国际,启迪药业行情,启迪药业股票行情,启迪药业股价,启迪药业股市,启迪药业股票价格,启迪药业股票交易,启迪药业股票购买,启迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"启迪药业(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供启迪药业(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}